Home > Advocacy > Global Psoriasis Coalition Statement on COVID-19

The Global Psoriasis Coalition, an IFPA program uniting patients, civil society and the corporate sector in promoting psoriasis on the international non-communicable disease policy agenda, has just published a statement on COVID-19 and people living with psoriasis and psoriatic arthritis.

The statement highlights the impact of COVID-19 in terms of disease, access to care, and quality of life, urging health authorities to take timely and appropriate measures to safeguard patients during the crisis.

To learn more about the Global Psoriasis Coalition and IFPA’s advocacy work, visit www.globalpsoriasiscoalition.org.


Translate »